翻訳と辞書 |
Patient Reported Outcome Indices for Multiple Sclerosis : ウィキペディア英語版 | Patient Reported Outcome Indices for Multiple Sclerosis The Patient Reported Outcome Indices for Multiple Sclerosis (PRIMUS) is a disease specific patient-reported outcome questionnaire which measures the quality of life (QoL) of patients suffering from multiple sclerosis. The measure contains an assessment of quality of life, activity limitations and symptoms. A higher score on any or all of these scales indicates a lower quality of life due to the disease. == History and Properties ==
First published in 2009 by Galen Research and funded by Novartis Pharmaceuticals, the PRIMUS was developed in order to provide a more holistic view of the impact of MS on a patient.〔 The measure has three scales: quality of life, symptoms and activity limitations, which are designed to be used together or as standalone measures.〔 The QoL and symptom scales are based on simple statements with dichotomous response options. Each scale has a total score which ranges from 0 to 22. The activity scale is based on 15 statements describing tasks. Patients are asked to rate their ability to perform these tasks on a scale from 1 to 3. The total score of the activities section ranges from 0 to 30.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Patient Reported Outcome Indices for Multiple Sclerosis」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|